Major histocompatibility complexes MHCs regulation

The T-lymphocyte receptor (TCR) is involved in detection of foreign antigens, presented together with the major histocompatibility complex (MHC). Subsequendy, it regulates the clonal expansion of T cells. 

Macrophage invasion — the up-regulation of the macrophage mannose receptor, cathepsin S, and macrophage capping protein. Up-regulation of irramme response genes — overexpression of major histocompatibility complex (MHC) and IgG. 

Finally, in this brief overview of lymphocyte defects, mention should be made of mutations affecting major histocompatibility-complex (MHC) Class II molecules. These mutations affect a multiprotein transcription factor complex that regulates the expression of MHC Class II molecules (121). Affected patients have undetectable levels of MHC Class II antigens HLA-DP, DQ, and DR on the surface of monocytes and B cells. Lack of these antigen-presenting molecules leads to impaired immune response. Affected individuals have moderate lymphopenia with a severely reduced number of CD4+ T cells and normal or increased numbers of CD8+ T cells. Since MHC molecules in the thymic epithelium play a key role in positive and negative selection of primitive T cells, selection of competent T cells is also affected in the absence of MHC Class II antigens. 

Regulation of major histocompatibility complex (MHC) expression by IL-1 may be cell and species dependent. IFNy-induced Class la expression on murine astrocytes is inhibited by IL-lp treatment. IL-ip is ineffective in modulating IFNy-induced Class II expression on murine microglia and Class I expression on astrocytes. Additionally, Class II expression on human fetal and adult astrocytes does not appear to be modulated by IL-1. 

Many SCLC patients mount an antitumor immune response without signs of PNS [9, 167, 174]. Nevertheless, most SCLC patients do not have this immune response. Thus, the rarity of PNS cannot be attributed to infrequency of antigen expression. This discrepancy suggests that additional factors, perhaps related to tumor major histocompatibility complex (MHC) expression, contribute to the initiation of the PNS immune response. A study of Hu antigen and MHC class I expression in SCLC and neuroblastoma supports this theory. Seventeen of 20 tumors from Hu antibody positive patients expressed both proteins, but only 4 of 30 specimens from seronegative individuals expressed both proteins [171]. Altered expression and/or down-regulation of MHC molecules is a common immune-evasive strategy of tumor cells [175],... 

Human leukocyte antigens are polymorphic cell-surface molecules that are intimately involved in the regulation of the immune response. The antigens are encoded by a series of closely linked genes known as the major histocompatibility complex (MHC), which is located on the short arm of chromosome 6 (BIO). The complex extends over approximately 4000 kilobases or 4 x 10 nucleotides and contains three distinct subregions known as class I, class II, and class III (T19) (see Fig. 1). 

Peptide-MHC Interaction Analysis The development of an anti-protein antibody response frequently requires activation of T-helper cells that induce B-cells to secrete specific antibodies. The key unit for regulation of this process is a trimolecular complex consisting of the T-cell receptor on T-cells, and the class II major histocompatibility complex (MHC) harboring an MHC-ligand on antigen presenting cells. The MHC-ligands are peptides derived... 

---